首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 15 毫秒
1.
Three 11C‐labelled tracers for the serotonin reuptake site, S‐[N‐methyl‐11C]citalopram ( [11C]‐4 ), S‐[N‐methyl‐d311C]citalopram ( [11C]‐12 ), and S‐[N‐methyl‐11C]citalopram‐α,α‐d2 ( [11C]‐13 ) were synthesized and the distribution of radioactivity after injection of radioligand was examined ex vivo in rats. The deuterated analogue of (S)‐desmethylcitalopram, (S)‐1‐(4‐fluorophenyl)‐1‐(3‐methylamino‐[3‐d2]‐propyl)‐1,3‐di‐hydro‐isobenzofuran‐5‐carbonitrile ( 11 ), was synthesized in a multi‐step synthesis from escitalopram ( 4 ) and used as precursor in the synthesis of [11C]‐13 . In analogy with the reported gas phase synthesis of [ 11 C]methyl iodide the first gas phase synthesis of [11C]Methyl iodide‐d3 is reported. The 1H/2H kinetic isotope effect related to the synthesized compounds were investigated in ex vivo rat studies, where the brain regions of interest to cerebellum ratios of the tracers [11C]‐4 , [11C]‐12 and [11C]‐13 were compared. The ex vivo data indicated no significant differences in binding in any of the investigated brain regions after injection of the three tracers. Copyright © 2004 John Wiley & Sons, Ltd.  相似文献   

2.
N‐(2,5‐Dimethoxybenzyl)‐N‐(5‐fluoro‐2‐phenoxyphenyl)acetamide (DAA1106), a potent and selective ligand for peripheral benzodiazepine receptor, and eight structurally related analogues were labelled with 11C at the carbonyl position using a low concentration of [11C]carbon monoxide and the micro‐autoclave technique. A combinatorial approach was applied to synthesize the analogues using similar reaction conditions. Palladium‐mediated carbonylation using tetrakis(triphenylphosphine)palladium, various amines and methyl iodide or iodobenzene was employed in the synthesis. The 11C‐labelled products were obtained with 10–55% decay‐corrected radiochemical yields and the final product was more than 97% pure in all cases. Specific radioactivity was determined for the compound [carbonyl11C]DAA1106 using a single experiment and a 10‐µA h bombardment. The specific radioactivity, measured 36 min after end of bombardment, was 455 GBq/µmol. Synthetic routes to the precursors and reference compounds were also developed. The presented approach is a novel method for the synthesis of [carbonyl11C]DAA1106 and its analogues, and allows the formation of a library of 11C‐labelled DAA1106 analogues which can be used to optimize the performance as a potential positron emission tomography tracer. Copyright © 2007 John Wiley & Sons, Ltd.  相似文献   

3.
The N‐ or O‐methylation reactions of compounds bearing amide, aniline, or phenol moieties using iodo[11C]methane (1) with the aid of a base are frequently applied to the preparation of 11C‐labeled radiopharmaceuticals. Although sodium hydride and alkaline metal hydroxides are commonly employed as bases in these reactions, their poor solubility properties in organic solvents and hydrolytic activities have sometimes limited their application and made the associated 11C‐methylation reactions difficult. In contrast to these bases, tetrabutylammonium fluoride (TBAF) is moderately basic, highly soluble in organic solvents, and weakly nucleophilic. Although it was envisaged that TBAF could be used as the preferred base for 11C‐methylation reactions using 1, studies concerning the use of TBAF to promote 11C‐methylation reactions are scarce. Herein, we have evaluated the efficiency of the 11C‐methylation reactions of 13 model compounds using TBAF and 1. In most cases, the N11C‐methylations were efficiently promoted by TBAF in dimethyl sulfoxide at ambient temperature, whereas the O11C‐methylations required heating in some cases. Comparison studies revealed that the efficiencies of the 11C‐methylation reactions with TBAF were comparable or sometimes greater than those conducted with sodium hydride. Based on these results, TBAF should be considered as the preferred base for 11C‐methylation reactions using 1.  相似文献   

4.
In this paper we present the radiochemical synthesis of the novel compound [N‐methyl‐11C]methylene blue. The synthesis of [N‐methyl‐11C]methylene blue was accomplished by means of 11C‐methylation of commercially available Azure B using [11C]methyl trifluoromethanesulfonate ([11C]methyl triflate). Following purification [N‐methyl‐11C]methylene blue was obtained with a radiochemical purity greater than 97% in a 4–6% decay corrected radiochemical yield. The synthesis was completed in an average of 35 min following the end of bombardment. Copyright © 2003 John Wiley & Sons, Ltd.  相似文献   

5.
The rapid, simple and high‐yield synthesis of the extraordinarily reactive 11C‐methylating agent, [11C]methyl nona‐fluorobutyl‐1‐sulfonate ([11C]MeONf), and its use in the synthesis of the promising β‐amyloid imaging agent, [11C]‐6‐OH‐BTA‐1, is reported. In terms of radioactive methylation yields, [11C]MeONf seems to surpass [11C]methyl trifluoromethansulfonate ([11C]MeOTf) as a methylating agent in this particular case giving the 11C‐labelled compound in high‐preparative radiochemical yields between 27 and 29% EOS with a minimum formation of radioactive by‐products. Copyright © 2007 John Wiley & Sons, Ltd.  相似文献   

6.
Within a novel series of 2‐oxazolidinones developed in the past by Sanofi‐Synthélabo, SL25.1188 ((S)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[d]isoxazol‐3‐yl]oxazolidin‐2‐one), a compound that inhibits selectively and competitively MAO‐B in human and rat brain (Ki values of 2.9 and 8.5 nM for MAO‐B, respectively, and ED50 (rat): 0.6 mg/kg p.o.), was considered an appropriate candidate for imaging this enzyme with positron emission tomography. SL25.1188 was labelled with carbon‐11 (T1/2: 20.38 min) in one chemical step using the following process: (i) reaction of [11C]phosgene with the corresponding ring‐opened precursor (1.2–2.5 mg) at 100°C for 2 min in dichloromethane (0.5 mL) followed by (ii) concentration to dryness of the reaction mixture and finally (iii) semi‐preparative HPLC purification on a Waters Symmetry® C18. A total of 300–500 MBq of [11C]SL25.1188 (>95% chemically and radiochemically pure) could be obtained within 30–32 min (Sep‐pak‐based formulation included) with specific radioactivities ranging from 50 to 70 GBq/µmol (3.5–7% decay‐corrected radiochemical yield, based on starting [11C]CH4). Copyright © 2008 John Wiley & Sons, Ltd.  相似文献   

7.
Racemic (±) verapamil is a well characterized substrate for P‐glycoprotein (P‐gp). However, the in vivo pharmacokinetics and pharmacodynamics of both enantiomers are reported to be different. In the preparation of evaluation studies of both enantiomers in animals and humans, the purpose of the present study was to optimize and automate the synthesis of (R)‐ and (S)‐[11C]verapamil. (R)‐ and (S)‐[11C]verapamil were prepared from (R)‐ and (S)‐desmethyl‐verapamil, respectively, by methylation with no‐carrier added [11C]methyliodide or [11C]methyltriflate. Different conditions of the methylation reaction were studied: reaction time, temperature, base and solvent, and chemical form of the precursor using either the hydrochloric acid salt or the free base of the starting material. After optimization, the synthesis was fully automated using home‐made modules and performed according to GMP guidelines. Optimal yields of 60–70% for the methylation reaction were obtained using 1.5 mg of the free base of (R)‐ or (S)‐desmethyl‐verapamil in 0.5 ml of acetonitrile at 50°C for 5 min with [11C]methyltriflate as methylating agent. Under the same reaction conditions, but with a reaction temperature of 100°C, the radiochemical yield starting with [11C]methyliodide as methylation reagent was 40%. The specific activity of (R)‐ and (S)‐[11C]verapamil was >20 GBq/μmol and the radiochemical purity was >99% for both methods. The total synthesis time was 45 min. The automated high yield synthesis of (R)‐ and (S)‐[11C]verapamil provides the means for evaluating both enantiomers as in vivo tracers of P‐gp function. Copyright © 2002 John Wiley & Sons, Ltd.  相似文献   

8.
The acetate salt of 2,5‐bis[5‐amidino‐2‐pyridyl]furan‐d2/15N2 ( 4) was synthesized from 2,5‐bis[5‐cyano‐2‐pyridyl]furan‐d2 ( 2 ), through the bisO‐acetoxyamidoxime followed by hydrogenation. Compound 2 was obtained via a Stille coupling reaction of 6‐chloronicotinonitrile with 2,5‐bis[tri‐n‐butyltin]‐furan‐d2 ( 1 ). 2,5‐bis[5‐amidino‐2‐pyridyl)furan‐d6 ( 10) was synthesized from 2,5‐bis[5‐cyano‐2‐pyridyl)furan‐d6 ( 9 ) via a direct reaction with lithium bis(trimethylsilyl)amide, followed by deprotection with ethanolic HCl. 15N and/or deuterium‐labelled methoxy‐amidines 5a ‐d2/15N2, 5b ‐d8, 12 , 14 ‐d6 were prepared in good yield via direct methylation of their respective diamidoximes with either dimethylsulfate‐d0 or dimethylsulfate‐d6 in DMF solution and using LiOH as a base. Copyright © 2006 John Wiley & Sons, Ltd.  相似文献   

9.
In this paper, we describe the radiosynthesis of the compound (E)‐2,3′,4,5′‐tetramethoxy[2‐11C]stilbene, a potential, universal tumour positron emission tomography imaging agent. The production of (E)‐2,3′,4,5′‐tetramethoxy[2‐11C]stilbene was carried out via 11C‐methylation of (E)‐2‐(hydroxy)‐3′,4,5′‐trimethoxystilbene by using [11C]methyl trifluoromethanesulfonate ([11C]methyl triflate). (E)‐2,3′,4,5′‐tetramethoxy[2‐11C]stilbene was obtained with a radiochemical purity greater than 95% in a 20 ± 2% decay‐corrected radiochemical yield, based upon [11C]carbon dioxide. Synthesis, purification and formulation were completed on an average of 30 min following the end of bombardment (EOB). The specific radioactivity obtained was 1.9 ± 0.6 GBq/µmol at EOB. Copyright © 2007 John Wiley & Sons, Ltd.  相似文献   

10.
Carboxylic acid derivatives of the amyloid‐binding dye Congo red do not enter the brain well and are thus unable to serve as in vivo amyloid‐imaging agents. A neutral amyloid probe, (E,E)‐1‐(3′,4′‐dihydroxystyryl)‐4‐(3′‐methoxy‐4′‐hydroxystyryl)benzene ( 3 ), devoid of any carboxylate groups has been designed and synthesized via a 12‐step reaction sequence with a total yield of 30%. The unsymmetric compound 3 has also been labelled with C‐11 via [11C]methyl iodide ([11C]CH3I) methylation of a symmetric 4,4′‐dimesyl protected precursor followed by deprotection. Preliminary evaluation indicated that compound 3 selectively stained plaques and neurofibrillary tangles in post‐mortem AD brain, and exhibited good binding affinity (Ki=38±8 nM) for Aβ(1–40) fibrils in vitro. In vivo pharmacokinetic studies indicated that [11C] 3 exhibited higher brain uptake than its carboxylic acid analogs and good clearance from normal control mouse brain. [11C] 3 also exhibited specific in vivo binding to pancreatic amyloid deposits in the NOR‐beta transgenic mouse model. These results justify further investigation of 3 and similar derivatives as surrogate markers for in vivo quantitation of amyloid deposits. Copyright © 2002 John Wiley & Sons, Ltd.  相似文献   

11.
Rhodium‐mediated carbonylation reaction was applied to synthesize diethyl [carbonyl11C]malonate using [11C]carbon monoxide at low concentration. The synthesis was performed starting with ethyl diazoacetate, ethanol and the rhodium complex being made in situ by chloro(1,5‐cyclooctadiene)rhodium(I) dimer ([Rh(cod)Cl]2) and 1,2‐bis(diphenylphosphino)ethane (dppe), and the reaction is assumed to proceed via a ketene intermediate. The isolated radiochemical yield was 20% (75% analytical radiochemical yield) and the trapping efficiency of [11C]carbon monoxide in the order of 85%. The specific radioactivity of this compound was measured at 127 GBq/µmol (7.28 nmol total mass) after 8 µAh bombardment and 35 min synthesis. The corresponding 13C‐labelled compound was synthesized using (13C)carbon monoxide to confirm the position of the carbonyl‐labelled atom by 13C‐NMR. Diethyl [carbonyl11C]malonate was further used in subsequent alkylation step using ethyl iodide and tetrabutylammonium fluoride to obtain diethyl diethyl [carbonyl11C]malonate in 50% analytical radiochemical yield. Copyright © 2006 John Wiley & Sons, Ltd.  相似文献   

12.
Reminyl® is a newly approved drug, used in the treatment of mild to moderate Alzheimer disease. The active compound, galantamine, was initially isolated from the bulbs of certain Narcissus species, but is at the moment also produced synthetically. In the process leading to the final approval, the synthesis of tritium‐, carbon‐14‐ and stable‐isotope‐labelled galantamine for pharmacokinetic studies was required. Racemic (±)‐1‐bromonarwedine, a compound available as intermediate from the commercial synthesis, was transformed to racemic 1‐bromo‐galantamine. Catalytic bromo‐tritium exchange, followed by HPLC purification and resolution afforded tritium‐labelled galantamine. The [14C]‐label was introduced on the nitrogen as well as on the oxygen‐methyl position. This was achieved by N‐ and O‐demethylation of galantamine and reaction of the thoroughly purified intermediate with [14C]‐methyl iodide. Stable‐isotope‐labelled galantamine was obtained likewise by 13CD3OD‐methylation of O‐demethylated galantamine under Mitsunobu conditions. Copyright © 2002 John Wiley & Sons, Ltd.  相似文献   

13.
A method has been developed for the synthesis of two isotopically labelled forms of a pro‐drug of the acetylcholinesterase inhibitor (?)‐huperzine A. These labelled compounds,[14C]ZT‐1 (Debio‐9902) and [d3]ZT‐1, were used in clinical studies to evaluate a potential treatment for Alzheimer's disease. The pro‐drug [14C]ZT‐1 was isolated with a radiochemical purity of >98% and a gravimetric specific activity of 129 μCi/mg in a seven‐step synthesis starting from [U‐14C]phenol in 7% yield. Subsequently, the deuterium labelled target (?)‐[d3]huperzine A was achieved in six steps with an overall yield of 15% and gave an isotopic distribution of d2 (1.65% huperzine A) and d3 (97.93% huperzine A) with a chemical purity of 98.5%. Condensation of the substrate (?)‐[d3]huperzine A with 5‐chloro‐o‐vanillin gave the Schiff base [d3]ZT‐1 in a chemical yield of 80%. Reduction of the Schiff base gave reduced‐[d3]ZT‐1, which was converted into the hydrochloride salt with an isotopic distribution of d2 (1.60%) and d3 (98.02%). Copyright © 2011 John Wiley & Sons, Ltd.  相似文献   

14.
The novel CCK‐A agonist, (S)‐3‐(3‐{1‐[(isopropylphenylcarbamoyl)methyl]‐2,4‐dioxo‐5‐phenyl‐2,3,4,5‐tetrahydro‐1H‐benzo[b][1,4]diazepin‐3‐yl}ureido)benzoic acid, GI181771 ((S)‐ 1 ) has been isotopically labelled with carbon‐11 at its urea site using [11C]phosgene in a one‐pot two‐step process, via the intermediate preparation of an [11C]isocyanate derivative. Optimized conditions for the preparation of (S)‐[11C]‐ 1 were the following: (1) Trapping of [11C]phosgene (radiosynthesized from cyclotron‐produced [11C]methane via [11C]carbon tetrachloride using minor modifications of published processes) at room temperature for 1–2 min in 300 µl of acetonitrile containing 0.6 µmol of the appropriate (structurally complex) chiral‐amine giving the corresponding [11C]isocyanate followed by (2) addition of an excess of 3‐aminobenzoic acid (40 µmol in 100 µl of THF) as the second amine giving the desired urea derivative (S)‐[11C]‐ 1 and (3) high‐performance liquid chromatography (HPLC) purification on a semi‐preparative Waters Symmetry® C18. Starting from a typical 1.2 Ci (44.4 GBq) batch of [11C]methane, 25–35 mCi (0.92–1.29 GBq, 6.8–9.6% decay‐corrected yield based on starting [11C] methane, n = 5) of (S)‐[11C]‐ 1 could be obtained within 35 min of radiosynthesis (HPLC purification and formulation as an i.v. injectable solution using a home‐made Sep‐pak®Plus C18 device included) with specific radioactivities ranging from 500 to 1500 mCi/µmol (18.5–55.5 GBq/µmol). The radiotracer preparation was a clear and colourless solution and its pH was between 5 and 7. As demonstrated by HPLC analysis, the radiolabelled product was found to be >99% chemically and radiochemically pure and the preparation was shown to be free of non‐radioactive precursors (starting amines) and radiochemically stable for at least 60 min. Finally, enantiomeric purity was found to be >99% according to chiral HPLC, demonstrating the absence of racemization during the process. Copyright © 2005 John Wiley & Sons, Ltd.  相似文献   

15.
2‐(4‐Methoxyphenyl)‐N‐(4‐methylbenzyl)‐N‐(1‐methylpiperidin‐4‐yl)acetamide (AC90179, 4 ), a highly potent and selective competitive 5‐HT2A antagonist, was labeled by [11C]‐methylation of the corresponding desmethyl analogue 5 with [11C]methyl triflate. The precursor molecule 5 for radiolabeling was synthesized from p‐tolylmethylamine in three steps with 46% overall yield. [11C]AC90179 was synthesized in 30 min (30 ± 5% yield, EOS) with a specific activity of 4500 ± 500 Ci/mmol and >99% chemical and radiochemical purities. Positron emission tomography studies in anesthetized baboon revealed that [11C] 4 Penetrates the blood–brain barrier (BBB) with a rapid influx and efflux of the tracer in all brain regions. Due to lack of tracer retention or specific binding, [11C] 4 cannot be used as PET ligand for imaging 5‐HT2A receptors. Copyright © 2006 John Wiley & Sons, Ltd.  相似文献   

16.
A method for the preparation of multi‐gramme quantities of N‐methyl‐d3N‐nitroso‐p‐toluenesulfonamide (Diazald‐d3) and N‐methyl‐13C‐N‐nitroso‐p‐toluenesulfonamide (Diazald‐13C) and their conversion to diazomethane‐d2 and diazomethane‐13C, respectively, is presented. This approach uses robust and reliable chemistry, and critically, employs readily commercially available and inexpensive methanol as the label source. Several reactions of labelled diazomethane are also reported, including alkene cyclopropanation, phenol methylation and α‐diazoketone formation, as well as deuterium scrambling in the preparation of diazomethane‐d2 and subsequent methyl esterification of benzoic acid.  相似文献   

17.
A convenient synthesis of [N‐methyl‐11C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐N,N‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine (R121920), a highly selective CRF1 antagonist has been developed as a potential PET ligand. 3 ‐ [(6 ‐ methylamino)pyridin ‐ 3 ‐ yl]‐2,5‐dimethyl‐N,N‐dipropylpyrazolo [1,5‐a]pyrimidine‐7‐amine ( 7 ), the precursor for radiolabelling was synthesized through a novel palladium catalyzed Suzuki coupling of aryl bromide 5 with heteroaryl boronate ester 4 . The requisite boronate ester 4 was synthesized in four steps from 2‐amino‐4‐bromopyridine in 50% overall yield. Although the synthesis of cold R121920 proceeded in 93% yield by sodium hexamethyl‐disilazide (NaHMDS) mediated N‐methylation of the desmethylamine 7 at ?78°C, the attempted radiosynthesis under various conditions using conventional bases were not successful. However, the radiolabeling of [11C]R121920 was successfully carried out with [11C]MeOTf in acetone at ?20°C in the absence of added basic reagents. The radiotracer was purified by RP‐HPLC followed by RP‐solid phase extraction. The yield of the reaction was 5% (at EOB) and the specific activity was >1000 Ci/mmol (at EOB) with a radiochemical purity >99%. Copyright © 2003 John Wiley & Sons, Ltd.  相似文献   

18.
Clinical findings using [11C]methyl 1‐[(1R)‐1‐phenylethyl]‐1H‐imidazole‐5‐carboxylate ([11C]MTO, 1) show high uptake in lesions of adrenocortical origin, including adenomas, but low uptake in lesions of non‐adrenocortical origin. In this paper the synthesis and preclinical evaluation of two new 11C‐labelled analogues of MTO, [11C]methyl 1‐[(1R)‐1‐(4‐chlorophenyl)ethyl]‐1H‐imidazole‐5‐carboxylate ([11C]CLM, 2) and [11C]methyl 1‐[(1R)‐1‐(4‐bromophenyl)ethyl]‐1H‐imidazole‐5‐carboxylate ([11C]BRM, 3), using frozen‐section autoradiography, organ distribution and a metabolic study are presented. Copyright © 2008 John Wiley & Sons, Ltd.  相似文献   

19.
[11C]Hydroxyurea has been successfully labelled using [11C]carbon monoxide at low concentration. The decay‐corrected radiochemical yield was 38±3%, and the trapping efficiency of [11C]carbon monoxide in the order of 90±5%. This synthesis was performed by a rhodium‐mediated carbonylation reaction starting with azidotrimethylsilane and the rhodium complex being made in situ by chloro(1,5‐cyclooctadiene)rhodium(I) dimer ([Rh(cod)Cl]2) and 1,2‐bis(diphenylphosphino)ethane (dppe). (13C)Hydroxyurea was synthesized using this method and the position of the labelling was confirmed by 13C‐NMR. In order to perform accurate LC–MS identification, the derivative 1‐hydroxy‐3‐phenyl[11C]urea was synthesized in a 35±4% decay‐corrected radiochemical yield. After 13 µA h bombardment and 21 min synthesis, 1.6 GBq of pure 1‐hydroxy‐3‐phenyl[11C]urea was collected starting from 6.75 GBq of [11C]carbon monoxide and the specific radioactivity of this compound was in the order of 686 GBq/µmol (3.47 nmol total mass). [11C]Hydroxyurea could be used in conjunction with PET to evaluate the uptake of this anticancer agent into tumour tissue in individual patients. Copyright © 2006 John Wiley & Sons, Ltd.  相似文献   

20.
A novel tritium or flourine‐18‐labelled benzamidine‐containing NR2B‐selective NMDA receptor ligand has been synthesized. This compound was designed to contain the fluoromethoxy group to allow for the synthesis of a high specific activity, fluorine‐18‐labelled PET tracer for imaging studies of the NR2B receptor. In addition to the fluorine‐18‐labelled compound, this compound was also tritium labelled. The tritiated ligand (11 Ci/mmol) was synthesized by a gas tritiation reaction of an aryl bromide precursor. The fluorine‐18 ligand (2916 Ci/mmol), which was deuterated in the fluoromethoxy group to aid in metabolic stability, was synthesized by alkylating a phenolic precursor with [18F]fluoromethylbromide‐d2. Copyright © 2004 John Wiley & Sons, Ltd.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号